# LLM Judge Evaluation Report: tier1_002

## Overall Assessment: PASS

### Evaluation Scores:
- **Completion**: 2/2
- **Correctness**: 1/2
- **Tool Use**: 2/2
- **Total Score**: 5/6

### Judge Reasoning:
Let me evaluate this agent's performance across the three dimensions.

First, I need to search for literature values of gabapentin's pKa to validate the correctness of the computed results.

### Specific Feedback:
- **Strengths**: The agent successfully completed the computational workflow, used appropriate tools in logical sequence, and provided meaningful interpretation of results in the context of stomach pH.
- **Areas for improvement**: The computed pKa values show moderate deviations from literature values (0.7-1.2 units off), suggesting the computational method or parameters could be refined for better accuracy.
- **Scientific interpretation**: The agent correctly concluded that at stomach pH (1.5-3.5), the carboxyl group would be predominantly protonated since the pH is below the calculated pKa, though the literature pKa of 3.7 would make this conclusion even more definitive.
- Literature validation: Agent's computed values:
- Carboxyl group pKa: 4.42
- Amino group pKa: 9.48

Literature values from FDA drug label (https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020235s064_020882s047_021129s046lbl.pdf):
- pKa1 = 3.7 (carboxyl group)
- pKa2 = 10.7 (amino group)

Carboxyl group error analysis:
- Absolute error: |4.42 - 3.7| = 0.72 units
- Percent error: 19.5%

Amino group error analysis:
- Absolute error: |9.48 - 10.7| = 1.22 units  
- Percent error: 11.4%

Both values fall within the 0.5-1.5 unit range, warranting a 1/2 correctness score according to the rubric.

### Web Search Citations:
1. [NEURONTIN (gabapentin) - accessdata.fda.gov](https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020235s064_020882s047_021129s046lbl.pdf)
2. [NEURONTIN (gabapentin) - accessdata.fda.gov](https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020235s064_020882s047_021129s046lbl.pdf)
3. [NEURONTIN (gabapentin) - accessdata.fda.gov](https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020235s064_020882s047_021129s046lbl.pdf)
4. [NEURONTIN (gabapentin) - accessdata.fda.gov](https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020235s064_020882s047_021129s046lbl.pdf)

### Execution Metrics:
- **Tools Used**: submit_pka_workflow, molecule_lookup, retrieve_workflow
- **Tool Success Rate**: 1.00
- **Execution Time**: 6.0 minutes

---
*Evaluated using LLM Judge with Web Search*
